NCT06289699

Brief Summary

The goal of this prospective, international multi-centre pilot study is to assess the functionality and user experience of a new vital sign monitoring system in 20 patients and 20 nurses in the general ward at each centre. The patients will be monitored with a wireless, continuous vital sign monitoring systems and answer a questionnaire afterwards. They will in addition have vital signs monitored as per standard practice. The nurses will answer a questionnaire after having had the responsibility for a monitored patient for a full shift. The main aims are: To determine the frequency of alerts activated in the app in relation to the alerts that should be activated based on measured data, to explore current practices of in-hospital monitoring by semi-structured interviews to map differences across systems and to test nurse and patient satisfaction.

Trial Health

83
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
7mo left

Started Feb 2024

Typical duration for all trials

Geographic Reach
5 countries

5 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress81%
Feb 2024Dec 2026

First Submitted

Initial submission to the registry

January 22, 2024

Completed
1 month until next milestone

Study Start

First participant enrolled

February 26, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 4, 2024

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2026

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

August 12, 2025

Status Verified

August 1, 2025

Enrollment Period

2.4 years

First QC Date

January 22, 2024

Last Update Submit

August 11, 2025

Conditions

Keywords

continuous wireless vital sign monitoringvital sign deviationhealthcare system and cultureUser ExperiencePostoperative ComplicationsAcute Medical Conditions

Outcome Measures

Primary Outcomes (1)

  • Frequency of alerts activated in the app in relation to the alerts that should be activated based on measured data

    during monitoring period, on average 3 months

Secondary Outcomes (12)

  • Technical feasibility

    during monitoring period, on average 3 months

  • Alert relay to smartphones

    during monitoring period, on average 3 months

  • Response to alerts

    during monitoring period, on average 3 months

  • Patients experiences from being monitored with wCSVM.

    during monitoring period, on average 3 months

  • Relevance of alarms

    during monitoring period, on average 3 months

  • +7 more secondary outcomes

Other Outcomes (7)

  • Cumulative duration of SpO2<88% and SpO2 < 85%

    during monitoring period, on average 3 months

  • Cumulative duration of respiratory rate ≤ 5 min-1 and Respiratory rate > 24 min-1

    during monitoring period, on average 3 months

  • Cumulative duration of Heart rate > 130 min-1 and Heart rate ≤ 30 min-1

    during monitoring period, on average 3 months

  • +4 more other outcomes

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

20 Patients in the general ward (surgical or medical) will be monitored with wCVSM and answer a questionnaire afterwards. 20 nurses will answer a questionnaire after having had the responsibility for a monitored patient for a full shift (including a shift where monitoring is initiated or a shift where the patient is discharged). Therefore, multiple nurses can be interviewed per patient. Patients will in addition have vital signs monitored as per standard practice. Participants will be recruited from wards at the study sites.

You may qualify if:

  • Adults (≥18 years)
  • Expected stay in the hospital ≥2 days
  • Admitted for surgery with expected duration of surgery \>2 hours or admitted for acute medical condition with at least one of the following vital sign deviations within 24 hours of acute admission, recorded by the staff
  • RR \> 21 breaths pr minute
  • RR \< 11 breaths pr minute
  • Pulse (P) \> 91 beats pr minute
  • Pulse (P) \< 50 beats pr minute
  • SpO2 \< 94 % without oxygen supplementation
  • Systolic BP \< 110 mmHg
  • Systolic BP \> 220 mmHg

You may not qualify if:

  • Participant expected not to cooperate with study procedures.
  • Allergy to plaster or silicone.
  • Pacemaker or Implantable Cardioverter Defibrillator (ICD) device.
  • Inability to give informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

The Cleveland Clinic Foundation, General Anesthesiology

Cleveland, Ohio, 44195, United States

NOT YET RECRUITING

Universitätsklinikum Hamburg-Eppendorf (UKE), Zentrum für Anästhesiologie und Intensivmedizin, Klinik und Poliklinik für Anästhesiologie

Hamburg, 20246, Germany

COMPLETED

University Medical Center Groningen, Department of Anesthesiology

Groningen, 9700, Netherlands

RECRUITING

St. Olavs Hospital HF, Klinikk for anestesi og intensivmedisin

Trondheim, 7006, Norway

COMPLETED

Liverpool University Hospitals NHS Foundation Trust

Liverpool, L7 8YE, United Kingdom

NOT YET RECRUITING

MeSH Terms

Conditions

Postoperative Complications

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Christian S Meyhoff, MD, PhD

    Copenhagen University Hospital - Bispebjerg and Frederiksberg, Copenhagen, Denmark

    PRINCIPAL INVESTIGATOR
  • Eske K Aasvang, MD, DMSci

    Rigshospitalet, Copenhagen University, Copenhagen, Denmark

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Katja K Head of Clinical, MD

CONTACT

Eske Kvanner Aasvang, MD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor, PhD

Study Record Dates

First Submitted

January 22, 2024

First Posted

March 4, 2024

Study Start

February 26, 2024

Primary Completion (Estimated)

August 1, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

August 12, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Locations